Health Care [ 11/12 ] | Health Care Equipment & Supplies [ 62/76 ]
NASDAQ | Common Stock
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration.
It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.
Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 9, 24 | -0.67 Decreased by -39.58% | -1.39 Increased by +51.80% |
| May 14, 24 | -1.31 Increased by +81.01% | -7.60 Increased by +82.76% |
| Feb 20, 24 | -2.47 Decreased by -1.27 K% | -5.60 Increased by +55.89% |
| Nov 14, 23 | -0.61 Decreased by -408.33% | -3.04 Increased by +79.93% |
| Aug 14, 23 | -0.48 Decreased by -860.00% | -1.50 Increased by +68.00% |
| May 15, 23 | -6.90 Decreased by -9.76 K% | -2.10 Decreased by -228.57% |
| Mar 30, 23 | -0.18 Decreased by -260.00% | -0.22 Increased by +18.18% |
| Nov 14, 22 | -0.12 Increased by +29.41% | -0.15 Increased by +20.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 0.00 Decreased by N/A% | -783.73 K Increased by +55.70% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -865.97 K Increased by +79.73% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -1.55 M Decreased by -150.45% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.92 M Decreased by -57.45% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.77 M Decreased by -276.99% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -4.27 M Decreased by -519.62% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | 3.07 M Increased by +1.83 K% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -1.22 M Decreased by -139.40% | Decreased by N/A% Decreased by N/A% |